The first report on CAR T cells co-expressing CCR was from Di Stasi's team where they revealed that CCR4-modified CD30-CAR T cells improved homing and anti-tumor activity in a Hodgkin tumor model (38). This evidence concerns the gene CCR4 and neoplasm.